GINKGO BIOWORKS HOLDINGS INC ($DNA)

1 tracked superinvestor hold GINKGO BIOWORKS HOLDINGS INC (DNA), worth $22M combined, led by Andreas Halvorsen. Smart money is holding DNA as of the latest 13F filings.

Current price

$9.73

BiotechnologyNYSEUS

-15.8%

1Y

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and…

Market cap

$601M

P/E

-1.72

Div yield

0.0%

Revenue YoY

-25.1%

Analyst target

$8

Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.

Superinvestors holding

1

tracked 13F / N-PORT funds

Combined value

$22M

disclosed long exposure

Tier-1 conviction

1

concentrated holders

Net this quarter

0

0 buying · 0 selling

Smart money is holding DNA steady this quarter — buys and sells are balanced.

The smart-money take on DNA

GINKGO BIOWORKS HOLDINGS INC (DNA) is held by 1 tracked funds worth $22M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.

The largest position belongs to Andreas Halvorsen at 0.1% of their book — no single tracked manager treats it as an outsized, top-weighted bet.

Tracked holders were largely static this quarter — no new opens, adds or trims of size — suggesting the position is being held rather than actively traded.

Superinvestors holding DNA

InvestorMove% of their portfolioPosition value
1
Andreas Halvorsen

Viking Global Investors

Held0.1%$22M

Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.

Frequently asked

Which superinvestors own DNA?

1 tracked funds hold GINKGO BIOWORKS HOLDINGS INC (DNA), the largest being Andreas Halvorsen (Viking Global Investors) at 0.1% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.

Is smart money buying or selling DNA?

In the most recent 13F quarter, 0 tracked funds added or opened DNA and 0 trimmed it.

How much DNA do tracked funds hold?

Combined disclosed long exposure to DNA across tracked superinvestors is $22M as of the Mar 2026 filings.

Stocks often held alongside DNA

Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.